Samvedan Diagnostic And Research Centre Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 02-07-2024
- Paid Up Capital ₹ 0.48 M
as on 02-07-2024
- Company Age 19 Year, 6 Months
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 1.40 Cr
as on 02-07-2024
- Revenue %
(FY 2018)
- Profit 41.60%
(FY 2018)
- Ebitda 42.85%
(FY 2018)
- Net Worth -0.40%
(FY 2018)
- Total Assets -0.03%
(FY 2018)
About Samvedan Diagnostic And Research Centre
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.48 M.
The company has closed loans amounting to ₹1.40 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Shubhank Chandrakar and Shailja Chandrakar serve as directors at the Company.
- CIN/LLPIN
U85110CT2005PTC017648
- Company No.
017648
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
26 May 2005
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Chhattisgarh
Industry
Company Details
- Location
Durg, Chattisgarh, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Samvedan Diagnostic And Research Centre?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Shubhank Chandrakar  | Director | 04-Jul-2023 | Current |
| Shailja Chandrakar | Director | 26-May-2005 | Current |
Financial Performance and Corporate Structure Insights of Samvedan Diagnostic And Research Centre.
Samvedan Diagnostic And Research Centre Private Limited, for the financial year ended 2018, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 41.6% increase in profit. The company's net worth dipped by a decrease of 0.4%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Samvedan Diagnostic And Research Centre?
In 2018, Samvedan Diagnostic And Research Centre had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Bastar Botanics Private LimitedActive 10 years 8 monthsShubhank Chandrakar and Shailja Chandrakar are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Karnataka Bank Limited Creation Date: 31 Mar 2012 | ₹1.40 Cr | Satisfied |
How Many Employees Work at Samvedan Diagnostic And Research Centre?
Unlock and access historical data on people associated with Samvedan Diagnostic And Research Centre, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Samvedan Diagnostic And Research Centre, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Samvedan Diagnostic And Research Centre's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
